Greg Bohlmann is a seasoned independent consultant with a wealth of experience in business analysis, particularly within the industrial biotech and chemical sectors. His recent tenure as Director of Biochemical Business Development at DuPont Industrial Biosciences allowed him to spearhead innovative projects, most notably the...
Greg Bohlmann is a seasoned independent consultant with a wealth of experience in business analysis, particularly within the industrial biotech and chemical sectors. His recent tenure as Director of Biochemical Business Development at DuPont Industrial Biosciences allowed him to spearhead innovative projects, most notably the BioIsoprene collaboration with Goodyear Tire. This initiative not only highlighted his expertise in biofuels and process engineering but also underscored his ability to bridge the gap between cutting-edge biotechnology and practical industrial applications.
In his current role as an independent consultant, Greg leverages his extensive background to assist industrial biotech start-ups in identifying and capitalizing on new business opportunities. His approach is rooted in a thorough evaluation of market needs, enabling clients to navigate the complexities of the biotech landscape effectively. By advising senior management on current and future market trends, customer discovery, and competitor dynamics, Greg ensures that his clients remain economically competitive in a rapidly evolving industry.
Greg's skill set encompasses strategic planning, business development, and analysis, making him a valuable asset for organizations looking to innovate and grow. His deep understanding of biochemistry and biomass utilization further enhances his ability to provide insights that drive sustainable practices within the sector. As he continues to engage with emerging companies, Greg is committed to fostering advancements in biotechnology that not only meet market demands but also contribute to a more sustainable future.
